Monitor OTLK's stock price closely ahead of the July 16 special meeting — if it holds above $1.00, the reverse split may be less urgent; if it drifts lower, the split becomes more likely. The delisting risk has receded for now but remains a latent overhang.
Price Chart
Executive Summary
Outlook Therapeutics filed a DEFA14A supplement to its proxy statement, updating shareholders that it regained Nasdaq minimum bid price compliance as of June 25, 2026 after a prior delisting notice, but warning that the stock closed at only $1.68 on July 9 and remains vulnerable to re-listing risk if price falls below $1.00 again. The supplement emphasizes that the reverse stock split proposal remains relevant as a contingency against future non-compliance.
Key Facts
- Outlook Therapeutics received a Nasdaq delisting notice on February 18, 2026 for failing to maintain $1.00 minimum bid price
- On June 26, 2026, Nasdaq confirmed the company regained compliance as closing bid price was ≥ $1.00 for 10 consecutive business days (June 11–25, 2026)
- As of July 9, 2026, the closing price was $1.68 per share; the company warns it could decline below $1.00 again
- The board's reverse stock split authorization (Proposal No. 3) remains a contingency tool; if not implemented within one year of the meeting, further shareholder approval will be needed
Financial Impact
No financial figures disclosed; the filing addresses listing compliance only
Risk Factors
- Stock price could fall below $1.00 again, triggering renewed delisting proceedings
- If reverse split is implemented, it may cause temporary volatility and potential selling pressure
- Any failure to maintain Nasdaq listing standards could materially impair liquidity and capital access
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-082361 |
| Document: 0001104659-26-082361-index-headers.html | 0001104659-26-082361 |
| Document: 0001104659-26-082361-index.html | 0001104659-26-082361 |
| Document: 0001104659-26-082361.txt | 0001104659-26-082361 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 424B5 | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | Press Release | $0.7564 $0.6379 | ▼ −15.67% | ▼ −13.67% | $0.5778 (−23.61%) |
Aug 13, 2026 7w ago | Press Release | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Aug 12, 2026 7w ago | 8-K | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Jul 24, 2026 9w ago | 8-K | $1.07 $0.6090 | ▼ −42.82% | ▼ −46.12% | $0.5778 (−45.75%) |
Jul 24, 2026 10w ago | Press Release | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 23, 2026 10w ago | 8-K | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 22, 2026 10w ago | EFFECT | $1.34 $0.6901 | ▼ −48.50% | ▼ −51.40% | $0.5778 (−56.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access